查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1360304

莱姆病诊断市场（诊断测试：血清学测试、聚合酶链反应测试等；样本：血液、脑脊髓液等）- 全球产业分析、规模、份额、成长、趋势和预测，2023-2031 年

Lyme Disease Diagnostics Market (Diagnostic Test: Serological Test, Polymerase Chain Reaction Test, and Others; and Sample: Blood, Cerebrospinal Fluid, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

莱姆病诊断市场 - 报告范围

TMR 关于全球莱姆病诊断市场的报告研究了过去以及当前的成长趋势和机会，以获得 2023 年至 2031 年预测期内市场指标的宝贵见解。该报告提供了全球莱姆病诊断的收入2017- 2031年期间的市场，考虑2023年为基准年，2031年为预测年。该报告也提供了2023年至2031年全球莱姆病诊断市场的年复合成长率（CAGR%）。

该报告是经过广泛研究后编写的。初级研究涉及大部分研究工作，其中分析师对关键意见领袖、行业领导者和舆论製造者进行了采访。二次研究涉及参考主要参与者的产品文献、年度报告、新闻稿和相关文件，以了解莱姆病诊断市场。

市场概况
2023年市场价值 15亿美元
2031 年市场价值 21 亿美元
复合年增长率 3.8%

该报告深入研究了全球莱姆病诊断市场的竞争格局。全球莱姆病诊断市场的主要参与者已经确定，并且每一位参与者都根据各种属性进行了分析。公司概况、财务状况、最新发展和 SWOT 是本报告中介绍的全球莱姆病诊断市场参与者的属性。

目录

第一章：前言

第 2 章：假设与研究方法

第 3 章：执行摘要：全球市场

第 4 章：市场概述

  • 介绍
  • 概述
  • 市场动态
  • 2017-2031年全球市场分析与预测

第 5 章：关键见解

  • 莱姆病诊断测试的创新
  • 莱姆病的发生率和盛行率
  • 按地区/全球分類的监管情景
  • COVID-19 大流行对产业的影响（价值炼和短期/中期/长期影响）

第 6 章：全球市场分析与预测：透过诊断测试

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：透过诊断测试，2017-2031
    • 血清学检测
      • 酵素连结免疫吸附试验
      • 蛋白质印迹
    • 聚合酶炼式反应 (PCR) 测试
    • 其他的
  • 市场吸引力分析：透过诊断测试

第 7 章：全球市场分析与预测：按样本

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：依样本，2017-2031
    • 血
    • 脑脊髓液 (CSF)
    • 其他的
  • 市场吸引力分析：按样本

第 8 章：全球市场分析与预测：按最终用户

  • 简介与定义
  • 主要发现/进展
  • 市场价值预测：按最终用户，2017-2031
    • 医院
    • 诊断实验室
    • 其他的
  • 市场吸引力分析：按最终用户

第 9 章：全球市场分析与预测：按地区

  • 主要发现
  • 市场价值预测：按地区，2017-2031
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：按地区

第 10 章：北美市场分析与预测

第 11 章：欧洲市场分析与预测

第 12 章：亚太市场分析与预测

第 13 章：拉丁美洲市场分析与预测

第 14 章：中东和非洲市场分析与预测

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 市占率分析：依公司划分（2022 年）
  • 公司简介
    • LabCorp
    • Quest Diagnostics
    • Abbott Laboratories
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • DiaSorin SpA
    • T2 Biosystems, Inc.
    • F. Hoffmann-La Roche AG
    • Meridian Bioscience, Inc.
    • Quidel Corporation
Product Code: TMRGL1658

Lyme Disease Diagnostics Market - Scope of Report

TMR's report on the global lyme disease diagnostics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global lyme disease diagnostics market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global lyme disease diagnostics market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the lyme disease diagnostics market.

Market Snapshot
Market Value in 2023US$ 1.5 Bn
Market Value in 2031US$ 2.1 Bn
CAGR3.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global lyme disease diagnostics market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global lyme disease diagnostics market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global lyme disease diagnostics market.

The report delves into the competitive landscape of the global lyme disease diagnostics market. Key players operating in the global lyme disease diagnostics market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global lyme disease diagnostics market profiled in this report.

Key Questions Answered in Global Lyme Disease Diagnostics Market Report:

  • What is the sales/revenue generated by lyme disease diagnostics across all regions during the forecast period?
  • What are the opportunities in the global lyme disease diagnostics market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Lyme Disease Diagnostics Market - Research Objectives and Research Approach

The comprehensive report on the global lyme disease diagnostics market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global lyme disease diagnostics market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global lyme disease diagnostics market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Lyme Disease Diagnostics Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Lyme Disease Diagnostics Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projection (US$ Mn)

5. Key Insights

  • 5.1. Innovations in Diagnostic Testing for Lyme disease
  • 5.2. Incidence and Prevalence of Lyme Disease
  • 5.3. Regulatory Scenario by Region/Globally
  • 5.4. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)

6. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Diagnostic Test

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 6.3.1. Serological Test
      • 6.3.1.1. ELISA
      • 6.3.1.2. Western Blot
    • 6.3.2. Polymerase Chain Reaction (PCR) test
    • 6.3.3. Others
  • 6.4. Market Attractiveness Analysis, by Diagnostic Test

7. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Sample

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Sample, 2017-2031
    • 7.3.1. Blood
    • 7.3.2. Cerebrospinal Fluid (CSF)
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Sample

8. Global Lyme Disease Diagnostics Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Diagnostic Laboratories
    • 8.3.3. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Lyme Disease Diagnostics Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region, 2017-2031
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Lyme Disease Diagnostics Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 10.2.1. Serological Test
      • 10.2.1.1. ELISA
      • 10.2.1.2. Western Blot
    • 10.2.2. Polymerase Chain Reaction (PCR) test
    • 10.2.3. Others
  • 10.3. Market Value Forecast, by Sample, 2017-2031
    • 10.3.1. Blood
    • 10.3.2. Cerebrospinal Fluid (CSF)
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Diagnostic Laboratories
    • 10.4.3. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Diagnostic Test
    • 10.6.2. By Sample
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Lyme Disease Diagnostics Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 11.2.1. Serological Test
      • 11.2.1.1. ELISA
      • 11.2.1.2. Western Blot
    • 11.2.2. Polymerase Chain Reaction (PCR) test
    • 11.2.3. Others
  • 11.3. Market Value Forecast, by Sample, 2017-2031
    • 11.3.1. Blood
    • 11.3.2. Cerebrospinal Fluid (CSF)
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Diagnostic Laboratories
    • 11.4.3. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Diagnostic Test
    • 11.6.2. By Sample
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Lyme Disease Diagnostics Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 12.2.1. Serological Test
      • 12.2.1.1. ELISA
      • 12.2.1.2. Western Blot
    • 12.2.2. Polymerase Chain Reaction (PCR) test
    • 12.2.3. Others
  • 12.3. Market Value Forecast, by Sample, 2017-2031
    • 12.3.1. Blood
    • 12.3.2. Cerebrospinal Fluid (CSF)
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Diagnostic Laboratories
    • 12.4.3. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Diagnostic Test
    • 12.6.2. By Sample
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Lyme Disease Diagnostics Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 13.2.1. Serological Test
      • 13.2.1.1. ELISA
      • 13.2.1.2. Western Blot
    • 13.2.2. Polymerase Chain Reaction (PCR) test
    • 13.2.3. Others
  • 13.3. Market Value Forecast, by Sample, 2017-2031
    • 13.3.1. Blood
    • 13.3.2. Cerebrospinal Fluid (CSF)
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Diagnostic Laboratories
    • 13.4.3. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Diagnostic Test
    • 13.6.2. By Sample
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Lyme Disease Diagnostics Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Diagnostic Test, 2017-2031
    • 14.2.1. Serological Test
      • 14.2.1.1. ELISA
      • 14.2.1.2. Western Blot
    • 14.2.2. Polymerase Chain Reaction (PCR) test
    • 14.2.3. Others
  • 14.3. Market Value Forecast, by Sample, 2017-2031
    • 14.3.1. Blood
    • 14.3.2. Cerebrospinal Fluid (CSF)
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Diagnostic Laboratories
    • 14.4.3. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Diagnostic Test
    • 14.6.2. By Sample
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 15.2. Market Share Analysis, by Company (2022)
  • 15.3. Company Profiles
    • 15.3.1. LabCorp
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Product Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. Quest Diagnostics
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Product Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Abbott Laboratories
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Product Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Bio-Rad Laboratories, Inc.
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Product Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. bioMerieux SA
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Product Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. DiaSorin S.p.A.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Product Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. T2 Biosystems, Inc.
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Product Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. F. Hoffmann-La Roche AG
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Product Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Meridian Bioscience, Inc.
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Product Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. Quidel Corporation
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Product Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 01: Global Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 02: Global Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2032
  • Table 03: Global Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 04: Global Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2032
  • Table 05: Global Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 07: North America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 08: North America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2032
  • Table 09: North America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 10: North America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 11: Europe Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 12: Europe Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 13: Europe Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 14: Europe Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 15: Europe Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 16: Asia Pacific Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 17: Asia Pacific Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 18: Asia Pacific Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 19: Asia Pacific Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 20: Asia Pacific Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 21: Latin America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic Test, 2017-2031
  • Table 22: Latin America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 23: Latin America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 24: Latin America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 25: Latin America Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 26: Middle East & Africa Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Diagnostic test, 2017-2031
  • Table 27: Middle East & Africa Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Serological Test, 2017-2031
  • Table 28: Middle East & Africa Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Sample, 2017-2031
  • Table 29: Middle East & Africa Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 30: Middle East & Africa Lyme Disease Diagnostics Market Size (US$ Mn) Forecast, by Region, 2017-2031

List of Figures

  • Figure 01: Global Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Lyme Disease Diagnostics Market Value Share, by Diagnostic Test, 2022
  • Figure 03: Global Lyme Disease Diagnostics Market Value Share, by Sample, 2022
  • Figure 04: Global Lyme Disease Diagnostics Market Value Share, by End-user, 2022
  • Figure 05: Global Lyme Disease Diagnostics Market Value Share, Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 06: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Serological Test, 2017-2031
  • Figure 07: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Polymerase Chain Reaction (PCR) Test, 2017-2031
  • Figure 08: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2023-2031
  • Figure 10: Global Lyme Disease Diagnostics Market Value Share, Analysis, by Sample, 2022 and 2031
  • Figure 11: Global Lyme Disease Diagnostics Market Revenue (US$ Mn) by Blood, 2017-2031
  • Figure 12: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Cerebrospinal Fluid (CSF), 2017-2031
  • Figure 13: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 14: Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2023-2031
  • Figure 15: Global Lyme Disease Diagnostics Market Value Share, Analysis, by End-user, 2022 and 2031
  • Figure 16: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Hospitals, 2017-2031
  • Figure 17: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Diagnostic Laboratories, 2017-2031
  • Figure 18: Global Lyme Disease Diagnostics Market Revenue (US$ Mn), by Others, 2017-2031
  • Figure 19: Global Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 20: Global Lyme Disease Diagnostics Market Value Share, Analysis, by Region, 2022 and 2031
  • Figure 21: Global Lyme Disease Diagnostics Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 22: North America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 23: North America Lyme Disease Diagnostics Market Value Share, Analysis, by Country, 2022 and 2031
  • Figure 24: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 25: North America Lyme Disease Diagnostics Market Value Share, Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 26: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2023-2031
  • Figure 27: North America Lyme Disease Diagnostics Market Value Share, Analysis, by Sample, 2022 and 2031
  • Figure 28: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2023-2031
  • Figure 29: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2032
  • Figure 30: North America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 31: Europe Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 32: Europe Lyme Disease Diagnostics Market Value Share, Analysis, by Country, 2022 and 2031
  • Figure 33: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 34: Europe Lyme Disease Diagnostics Market Value Share, Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 35: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2023-2031
  • Figure 36: Europe Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2022 and 2031
  • Figure 37: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2023-2031
  • Figure 38: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2032
  • Figure 39: Europe Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Asia Pacific Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 41: Asia Pacific Lyme Disease Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 42: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 43: Asia Pacific Lyme Disease Diagnostics Market Value Share, Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 44: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2023-2031
  • Figure 45: Asia Pacific Lyme Disease Diagnostics Market Value Share, Analysis, by Sample, 2022 and 2031
  • Figure 46: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2023-2031
  • Figure 47: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2032
  • Figure 48: Asia Pacific Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Latin America Lyme Disease Diagnostics Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 50: Latin America Lyme Disease Diagnostics Market Value Share, Analysis, by Country, 2022 and 2031
  • Figure 51: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 52: Latin America Lyme Disease Diagnostics Market Value Share, Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 53: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Diagnostic Test, 2023-2031
  • Figure 54: Latin America Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2022 and 2031
  • Figure 55: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by Sample, 2023-2031
  • Figure 56: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2032
  • Figure 57: Latin America Lyme Disease Diagnostics Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Middle East & Africa Lyme Disease Diagnostics Market Value (US$ Mn), 2017-2031
  • Figure 59: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Country, 2022 and 2031
  • Figure 60: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness, by Country, 2023-2031
  • Figure 61: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Diagnostic Test, 2022 and 2031
  • Figure 62: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness, by Diagnostic Test, 2023-2031
  • Figure 63: Middle East & Africa Lyme Disease Diagnostics Market Value Share Analysis, by Sample, 2022 and 2031
  • Figure 64: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness, by Sample, 2023-2031
  • Figure 65: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness, by End-user, 2023-2032
  • Figure 66: Middle East & Africa Lyme Disease Diagnostics Market Attractiveness, by End-user, 2023-2031
  • Figure 67: Company Share Analysis Lyme Disease Diagnostics, 2022